Table 2.
Psychopathology scores of the index group
| Score (mean±SD) | ||
|---|---|---|
| Parameter | Before treatment | After treatment |
| PANSS | ||
| Positive subscale | 19.1±6.4 | 8.3±1.3 |
| Negative subscale | 27.0±6.3 | 16.1±5.0 |
| General psychopathology subscale | 40.6±4.4 | 22.4±2.9 |
| MADRS | 18.6±7.2 | 11.6±4.8 |
| AIMS* | ||
| Simpson–Angus rating scale (for extrapyramidal symptoms) score† | ||
PANSS: Positive and Negative Syndrome Scale; MADRS: Montgomery–Asberg Depression Rating Scale; AIMS: Abnormal Involuntary Movement Scale
Three out of 15 patients had been suffering from mild to moderately severe tardive dyskinesia which neither deteriorated nor improved with treatment of short duration.
Among the experimental group, 11 patients developed antipsychotic-induced minimal to mild extrapyramidal symptoms that were significantly more than in the control group.